---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-047017"
form_type: "8-K"
ticker: "CELU"
cik: "0001752828"
company_name: "Celularity Inc"
filed_at: "2023-09-07T23:59:59+00:00"
generated_at: "2026-06-10T22:55:59.372726+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Celularity appoints Dr. Geoffrey Ling to board; Dr. von Eschenbach resigns

## Summary
- Dr. Andrew von Eschenbach resigned as Class I director effective August 31, 2023, not due to any disagreement.
- Dr. Geoffrey Shiu Fei Ling appointed as Class I director to fill the vacancy, effective August 31, 2023.
- Dr. Ling received a stock option for 1,250,000 shares at $0.324 exercise price, vesting over three years.
- Dr. Ling brings >30 years experience in pharma, academia, DARPA, and military; retired U.S. Army colonel.

## SEC filing metadata
- accession: 0000950170-23-047017
- form_type: 8-K
- ticker: CELU
- cik: 0001752828
- company_name: Celularity Inc
- filed_at: 2023-09-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1752828/000095017023047017/0000950170-23-047017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1752828/000095017023047017/celu-20230831.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-047017
- JSON: https://secwatch.observer/filing/0000950170-23-047017.json
- Plain text: https://secwatch.observer/filing/0000950170-23-047017.txt

## Key facts
- Executive change
  Geoffrey Shiu Fei Ling was appointed as Class I Director at Celularity Inc.
  - Action: appointed
  - Role: Class I Director
  source text: the board appointed Geoffrey Shiu Fei Ling, M.D., as a Class I director to fill the vacancy left by the resignation of Dr. von Eschenbach, to serve until his successor is elected and qualified
  evidence_url: https://www.sec.gov/Archives/edgar/data/1752828/000095017023047017/0000950170-23-047017-index.htm
- Executive change
  Andrew C. von Eschenbach resigned as Class I Director at Celularity Inc.
  - Action: resigned
  - Role: Class I Director
  source text: Andrew C. von Eschenbach, M.D., a Class I member of the board of directors of Celularity Inc., or Celularity, notified the board of directors of his intention to resign as a member of the board and all committees thereof effective August 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1752828/000095017023047017/0000950170-23-047017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.